Comparison of integrative medicine (acupuncture, Hypericum perforatum and life style modification) with life style modification in appetite and weight control
Red color represents old content. It may be empty showing addition in the new version.
Green color represents new content. It may be empty showing deletion in the new version.
Inline
Side by side
Added new contents,
deleted old contents,contents that are not changed.
New table contents
New table contents
Old table contents
Old table contents
Unchanged contents
Unchanged contents
Added new contents, contents that are not changed.
Deleted old contents, contents that are not changed.
Old table contents
Old table contents
Unchanged contents
Unchanged contents
New table contents
New table contents
Unchanged contents
Unchanged contents
Protocol summary
Nesfatin 1 levels؛ the appetite score; BMI; waist circumference; hip circumference; body composition
BMI; the appetite score; Nesfatin 1 level; waist circumference; hip circumference; body composition
Nesfatin 1 levels؛BMI; the appetite score; BMINesfatin 1 level; waist circumference; hip circumference; body composition
سطح نسفاتین 1؛ میزان اشتها؛ شاخص توده بدنی؛ دور کمر؛ دور هیپ؛ ترکیب بدن
شاخص توده بدنی؛ میزان اشتها؛ سطح نسفاتین 1؛ دور کمر؛ دور هیپ؛ ترکیب بدن
سطح نسفاتین 1شاخص توده بدنی؛ میزان اشتها؛ شاخص توده بدنیسطح نسفاتین 1؛ دور کمر؛ دور هیپ؛ ترکیب بدن
General information
Triple blinded
Single blinded
triplsingl
2018-10-23, 1397/08/01
2019-11-01, 1398/08/10
20182019-1011-2301 00:00:00
Appetite score more than 4 according to visual analogue scale
Body mass index between 24.9 to 39.9
Women 18 years old to pre-menopause; men 18 to 60 years old
Failure to life style modification alone
"Liver qi stagnation" syndrome according to Chinese Medicine syndrome differentiation
Appetite score more than 5 according to visual analogue scale
Body mass index between 24.9 to 39.9
Women 18 years old to pre-menopause; men 18 to 60 years old
Failure to life style modification alone
"Liver qi stagnation" syndrome according to Chinese Medicine syndrome differentiation
Appetite score more than 45 according to visual analogue scale Body mass index between 24.9 to 39.9 Women 18 years old to pre-menopause; men 18 to 60 years old Failure to life style modification alone "Liver qi stagnation" syndrome according to Chinese Medicine syndrome differentiation
اسکور اشتهای بیشتر از 4 بر اساس مقیاس دیداری
شاخص توده بدنی 24.9 تا 39.9
خانم های 18 ساله تا پره منوپوز؛ آقایان 18 تا 60 سال
شکست در تغییر شیوه زندگی به تنهایی
سندرم "رکود چی کبدی" بر اساس سندرم شناسی طب چینی
اسکور اشتهای بیشتر از 5 بر اساس مقیاس دیداری
شاخص توده بدنی 24.9 تا 39.9
خانم های 18 ساله تا پره منوپوز؛ آقایان 18 تا 60 سال
شکست در تغییر شیوه زندگی به تنهایی
سندرم "رکود چی کبدی" بر اساس سندرم شناسی طب چینی
اسکور اشتهای بیشتر از 45 بر اساس مقیاس دیداری شاخص توده بدنی 24.9 تا 39.9 خانم های 18 ساله تا پره منوپوز؛ آقایان 18 تا 60 سال شکست در تغییر شیوه زندگی به تنهایی سندرم "رکود چی کبدی" بر اساس سندرم شناسی طب چینی
empty
empty
Primary outcomes
#1
empty
Appetite score
Appetite score
empty
نمره اشتها
نمره اشتها
empty
Before intervention, weeks 2, 4, 6, 24
Before intervention, weeks 2, 4, 6, 24
empty
قبل از شروع مداخله، در هفته 2، 4، 6، 24
قبل از شروع مداخله، در هفته 2، 4، 6، 24
empty
Visual Analogue Scale
Visual Analogue Scale
empty
مقیاس دیداری
مقیاس دیداری
#2
empty
Body Mass Index
Body Mass Index
empty
شاخص توده بدنی
شاخص توده بدنی
empty
Before intervention, weeks 2, 6, 24
Before intervention, weeks 2, 6, 24
empty
قبل از شروع مداخله، هفته 2، 6 و 24
قبل از شروع مداخله، هفته 2، 6 و 24
empty
Using the bioelectrical impedance analyzer; kg/m2
Using the bioelectrical impedance analyzer; kg/m2
empty
با استفاده از دستگاه آنالیز بدن؛ بر حسب کیلوگرم بر متر مربع
با استفاده از دستگاه آنالیز بدن؛ بر حسب کیلوگرم بر متر مربع
Secondary outcomes
#1
Appetite score
Waist circumference
Appetite scoreWaist circumference
نمره اشتها
دور کمر
نمره اشتهادور کمر
Before intervention, weeks 2, 4, 6, 24
Before intervention, weeks 2, 6, 24
Before intervention, weeks 2, 4, 6, 24
قبل از شروع مداخله، در هفته 2، 4، 6، 24
قبل از شروع مداخله، هفته 2، 6 و 24
قبل از شروع مداخله، در هفته 2، 4، 6، و 24
Visual Analogue Scale
Using a tape measure; centimeters
Visual Analogue ScaleUsing a tape measure; centimeters
مقیاس دیداری
با استفاده از متر نواری؛ بر حسب سانتی متر
مقیاس دیداریبا استفاده از متر نواری؛ بر حسب سانتی متر
#2
Body Mass Index
Hip circumference
Body Mass IndexHip circumference
شاخص توده بدنی
دور هیپ
شاخص توده بدنیدور هیپ
Using the bioelectrical impedance analyzer; kg/m2
Using a tape measure; centimeters
Using the bioelectrical impedance analyzera tape measure; kg/m2centimeters
با استفاده از دستگاه آنالیز بدن؛ بر حسب کیلوگرم بر متر مربع
با استفاده از متر نواری؛ بر حسب سانتی متر
با استفاده از دستگاه آنالیز بدنمتر نواری؛ بر حسب کیلوگرم برسانتی متر مربع
#3
Waist circumference
Body composition
Waist circumferenceBody composition
دور کمر
ترکیب بدن
دور کمرترکیب بدن
Before intervention, weeks 2, 6, 24
Before intervention, weeks 2, 6
Before intervention, weeks 2, 6, 24
قبل از شروع مداخله، هفته 2، 6 و 24
قبل از شروع مداخله، هفته 2 و 6
قبل از شروع مداخله، هفته 2، 6 و 246
Using a tape measure; centimeters
Using the bioelectrical impedance analyzer
Using a tape measure; centimetersthe bioelectrical impedance analyzer
با استفاده از متر نواری؛ بر حسب سانتی متر
با استفاده از دستگاه آنالیز بدن
با استفاده از متر نواری؛ بر حسب سانتی متردستگاه آنالیز بدن
#4
Hip circumference
Lipid profile
Hip circumferenceLipid profile
دور هیپ
پروفایل لیپیدی
دور هیپپروفایل لیپیدی
Before intervention, weeks 2, 6, 24
Before intervention, week 6
Before intervention, weeks 2,week 6, 24
قبل از شروع مداخله، هفته 2، 6 و 24
قبل از شروع مداخله، هفته 6
قبل از شروع مداخله، هفته 2، 6 و 24
Using a tape measure; centimeters
Laboratory
Using a tape measure; centimetersLaboratory
با استفاده از متر نواری؛ بر حسب سانتی متر
آزمایشگاهی
با استفاده از متر نواری؛ بر حسب سانتی مترآزمایشگاهی
#5
Body composition
Liver enzymes
Body compositionLiver enzymes
ترکیب بدن
آنزیم های کبدی
ترکیب بدنآنزیم های کبدی
Before intervention, weeks 2, 6
Before intervention, week 6
Before intervention, weeks 2,week 6
قبل از شروع مداخله، هفته 2 و 6
قبل از شروع مداخله، هفته 6
قبل از شروع مداخله، هفته 2 و 6
Using the bioelectrical impedance analyzer
Laboratory
Using the bioelectrical impedance analyzerLaboratory
با استفاده از دستگاه آنالیز بدن
آزمایشگاهی
با استفاده از دستگاه آنالیز بدنآزمایشگاهی
#6
Lipid profile
Blood glucose level
Lipid profileBlood glucose level
پروفایل لیپیدی
سطح قند خون
پروفایل لیپیدیسطح قند خون
#7
Liver enzymes
Adverse events
Liver enzymesAdverse events
آنزیم های کبدی
عوارض جانبی
آنزیم های کبدیعوارض جانبی
Before intervention, week 6
During the study period within 48 to 72 hours of incidence; week 6
Before intervention,During the study period within 48 to 72 hours of incidence; week 6
قبل از شروع مداخله، هفته 6
در طول مطالعه در فاصله 48 تا 72 ساعت از زمان بروز؛ هفته 6
قبلدر طول مطالعه در فاصله 48 تا 72 ساعت از شروع مداخله،زمان بروز؛ هفته 6
Laboratory
Study checklist
LaboratoryStudy checklist
آزمایشگاهی
چک لیست مطالعه
آزمایشگاهیچک لیست مطالعه
#8
Blood glucose level
empty
Blood glucose level
سطح قند خون
empty
سطح قند خون
Before intervention, week 6
empty
Before intervention, week 6
قبل از شروع مداخله، هفته 6
empty
قبل از شروع مداخله، هفته 6
Laboratory
empty
Laboratory
آزمایشگاهی
empty
آزمایشگاهی
#9
Adverse events
empty
Adverse events
عوارض جانبی
empty
عوارض جانبی
During the study period within 48 to 72 hours of incidence; week 6
empty
During the study period within 48 to 72 hours of incidence; week 6
در طول مطالعه در فاصله 48 تا 72 ساعت از زمان بروز؛ هفته 6
empty
در طول مطالعه در فاصله 48 تا 72 ساعت از زمان بروز؛ هفته 6
Study checklist
empty
Study checklist
چک لیست مطالعه
empty
چک لیست مطالعه
Intervention groups
#1
Intervention group 1: acupuncture, 3 times per week + 4 Hypericum perforatum capsules (equivalent to 400 mg/day extract) + life style modification for 6 weeks
Intervention group 1: acupuncture, 3 times per week + 4 tablets of 160 mg Perforan (Goldaru company) + life style modification for 6 weeks
Intervention group 1: acupuncture, 3 times per week + 4 Hypericum perforatum capsulestablets of 160 mg Perforan (equivalent to 400 mg/day extractGoldaru company) + life style modification for 6 weeks
گروه مداخله 1: طب سوزنی، سه بار در هفته + 4 عدد کپسول هوفاریقون در روز (معادل 400 میلی گرم عصاره در روز) + تغییر شیوه زندگی به مدت 6 هفته
گروه مداخله 1: طب سوزنی، سه بار در هفته + 4 عدد قرص پرفوران 160 میلی گرمی (شرکت گل دارو) + تغییر شیوه زندگی به مدت 6 هفته
گروه مداخله 1: طب سوزنی، سه بار در هفته + 4 عدد کپسول هوفاریقون در روز (معادل 400قرص پرفوران 160 میلی گرم عصاره در روزگرمی (شرکت گل دارو) + تغییر شیوه زندگی به مدت 6 هفته
#2
Intervention group 2: acupuncture 3 times/week + placebo capsules + life style modification for 6 weeks
Intervention group 2: acupuncture 3 times/week + placebo tablets+ life style modification for 6 weeks
Intervention group 2: acupuncture 3 times/week + placebo capsules tablets+ life style modification for 6 weeks
گروه مداخله 2: طب سوزنی، 3 بار در هفته+ کپسول پلاسبو + تغییر شیوه زندگی به مدت 6 هفته
گروه مداخله 2: طب سوزنی، 3 بار در هفته+ قرص پلاسبو + تغییر شیوه زندگی به مدت 6 هفته
گروه مداخله 2: طب سوزنی، 3 بار در هفته+ کپسولقرص پلاسبو + تغییر شیوه زندگی به مدت 6 هفته
#3
Intervention group 3: sham acupuncture, 3 times/week+ 4 Hypericum perforatum capsules (equivalent to 400 mg/day extract) + life style modification for 6 weeks
Intervention group 3: sham acupuncture, 3 times/week+ 4 tablets of 160 mg Perforan (Goldaru company) + life style modification for 6 weeks
Intervention group 3: sham acupuncture, 3 times/week+ 4 Hypericum perforatum capsulestablets of 160 mg Perforan (equivalent to 400 mg/day extractGoldaru company) + life style modification for 6 weeks
گروه مداخله 3: طب سوزنی شم، 3 بار در هفته + 4 عدد کپسول هوفاریقون در روز (معادل 400 میلی گرم عصاره در روز) + تغییر شیوه زندگی به مدت 6 هفته
گروه مداخله 3: طب سوزنی شم، 3 بار در هفته + 4 عدد قرص پرفوران 160 میلی گرمی (شرکت گل دارو) + تغییر شیوه زندگی به مدت 6 هفته
گروه مداخله 3: طب سوزنی شم، 3 بار در هفته + 4 عدد کپسول هوفاریقون در روز (معادل 400قرص پرفوران 160 میلی گرم عصاره در روزگرمی (شرکت گل دارو) + تغییر شیوه زندگی به مدت 6 هفته
Protocol summary
Study aim
To determine and compare the effect of adding acupuncture and / or Hypericum perforatum to life style modification in appetite and weight control
Design
A randomized, sham controlled, parallel group, phase III clinical trial with blinded patients, nutritionist, outcome assessor and statistician
Settings and conduct
Eighty-eight overweight or obese patients with appetite score ≤ 5 out of 10 will be randomly assigned to one of four groups to be treated for 6 weeks in the acupuncture and nutrition clinics affiliated to Mashhad University of Medical Sciences. Patients, nutritionist, outcome assessor and statistician will be blinded to study groups. acupuncturist could not be blinded in this study.
Participants/Inclusion and exclusion criteria
Main inclusion criteria: People with BMI 24.9 to 39.9; women 18 years to premenopausal and men 18 to 60 years.
Main exclusion criteria: 1- ِdiseases affecting metabolism such as hypothyroidism 2- drugs affecting weight and metabolism or interfering with Hypericum perforatum 3- allergy to hypericum perforatum or metal
Intervention groups
1. Acupuncture + Hypericum perforatum + life style modification; 2. acupuncture + placebo + life style modification; 3. Sham acupuncture + Hypericum perforatum + life style modification; 4. sham acupuncture + placebo + life style modification
Main outcome variables
BMI; the appetite score; Nesfatin 1 level; waist circumference; hip circumference; body composition
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT201706107265N9
Registration date:2017-06-24, 1396/04/03
Registration timing:prospective
Last update:2019-09-17, 1398/06/26
Update count:2
Registration date
2017-06-24, 1396/04/03
Registrant information
Name
Hoda Azizi
Name of organization / entity
Mashhad University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 51 1855 2188
Email address
azizih@mums.ac.ir
Recruitment status
Recruitment complete
Funding source
Vice chancellor for research, Mashhad University of Medical Sciences
Expected recruitment start date
2017-10-23, 1396/08/01
Expected recruitment end date
2019-11-01, 1398/08/10
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of integrative medicine (acupuncture, Hypericum perforatum and life style modification) with life style modification in appetite and weight control
Public title
The effect of acupuncture, hypericum perforatum and diet in appetite and weight control
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Appetite score more than 5 according to visual analogue scale
Body mass index between 24.9 to 39.9
Women 18 years old to pre-menopause; men 18 to 60 years old
Failure to life style modification alone
"Liver qi stagnation" syndrome according to Chinese Medicine syndrome differentiation
Exclusion criteria:
Hypothyroidism, Cushing's syndrome, cancer, liver or kidney failure
Using drugs effective on appetite, weight and metabolism in the previous month
Using drugs that interfere with Hypericum perforatum such as protease inhibitors, amiodarone, anticoagulants, cyclophosphamide, cyclosporine, monoamine oxidase inhibitors, phenytoin, tacrolimus, tamoxifen and trazodone drug
Drug abuse or alcoholism
Breast-feeding, pregnancy or planning a pregnancy during the next two months
Having pacemaker or any other metal device inside the body due to the use of electroacupuncture and Bioelectrical Impedance Analyzer
disability to do recommended physical activity
Allergy to Hypericum perforatum or metal
Coagulation disorders
History of receiving acupuncture
Age
From 18 years old to 60 years old
Gender
Both
Phase
3
Groups that have been masked
Participant
Care provider
Outcome assessor
Data analyser
Sample size
Target sample size:
88
Randomization (investigator's opinion)
Randomized
Randomization description
Block randomization will be done using SPSS version 16 by selecting quadrants blocks.
Blinding (investigator's opinion)
Single blinded
Blinding description
Participants, the nutritionist, the outcome assessor, and the statistician will be blinded from the identity of the study groups. The acupuncturist will not be blinded. The participant blindness will be performed using sham acupuncture and placebo.
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics Committee of Mashhad University of Medical Sciences
Street address
Qorashi building, Daneshgah Street
City
Mashhad
Province
Razavi Khorasan
Postal code
91357345
Approval date
2017-06-06, 1396/03/16
Ethics committee reference number
IR.MUMS.REC.1396.43
Health conditions studied
1
Description of health condition studied
obesity
ICD-10 code
E66.0
ICD-10 code description
Obesity due to excess calories
Primary outcomes
1
Description
Plasma nesfatin-1
Timepoint
Before intervention, Sixth week
Method of measurement
Laboratory: ELISA
2
Description
Appetite score
Timepoint
Before intervention, weeks 2, 4, 6, 24
Method of measurement
Visual Analogue Scale
3
Description
Body Mass Index
Timepoint
Before intervention, weeks 2, 6, 24
Method of measurement
Using the bioelectrical impedance analyzer; kg/m2
Secondary outcomes
1
Description
Waist circumference
Timepoint
Before intervention, weeks 2, 6, 24
Method of measurement
Using a tape measure; centimeters
2
Description
Hip circumference
Timepoint
Before intervention, weeks 2, 6, 24
Method of measurement
Using a tape measure; centimeters
3
Description
Body composition
Timepoint
Before intervention, weeks 2, 6
Method of measurement
Using the bioelectrical impedance analyzer
4
Description
Lipid profile
Timepoint
Before intervention, week 6
Method of measurement
Laboratory
5
Description
Liver enzymes
Timepoint
Before intervention, week 6
Method of measurement
Laboratory
6
Description
Blood glucose level
Timepoint
Before intervention, week 6
Method of measurement
Laboratory
7
Description
Adverse events
Timepoint
During the study period within 48 to 72 hours of incidence; week 6
Method of measurement
Study checklist
Intervention groups
1
Description
Intervention group 1: acupuncture, 3 times per week + 4 tablets of 160 mg Perforan (Goldaru company) + life style modification for 6 weeks
Category
Other
2
Description
Intervention group 2: acupuncture 3 times/week + placebo tablets+ life style modification for 6 weeks
Category
Other
3
Description
Intervention group 3: sham acupuncture, 3 times/week+ 4 tablets of 160 mg Perforan (Goldaru company) + life style modification for 6 weeks
Category
Other
4
Description
Control group: sham acupuncture, 3 times/week + placebo + life style modification for 6 weeks
Category
Lifestyle
Recruitment centers
1
Recruitment center
Name of recruitment center
Acupuncture clinic, Imam Reza Hospital
Full name of responsible person
Dr. Hoda Azizi
Street address
Daneshgah Street
City
Mashhad
Province
Razavi Khorasan
Postal code
9137913316
Phone
+98 51 3802 2035
Email
azizih@mums.ac.ir
2
Recruitment center
Name of recruitment center
Nutrition clinic, Qaem Hospital
Full name of responsible person
Dr. Mohammad Safarian
Street address
Ahmadabad Street, Mashhad, Iran
City
Mashhad
Province
Razavi Khorasan
Postal code
9919991766
Phone
+98 51 3845 3239
Email
safarianm@mums.ac.ir
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Vice chancellor for research, Mashhad University of Medical Sciences
Full name of responsible person
Dr. Mohsen Tafaghodi
Street address
Qorashi Building, Daneshgah Street
City
Mashhad
Province
Razavi Khorasan
Postal code
91357345
Phone
+98 51 3841 2081
Email
tafaghodim@mums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Vice chancellor for research, Mashhad University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
School of Traditional and Complementary Medicine
Full name of responsible person
Dr. Monirsadat Sahebkar Khorasani
Position
PhD candidate
Latest degree
Medical doctor
Other areas of specialty/work
Traditional Medicine
Street address
Pardis daneshgah, Park Square
City
Mashhad
Province
Razavi Khorasan
Postal code
9177948564
Phone
+98 51 3882 9279
Fax
Email
sahebkarm931@mums.ac.ir
Web page address
Person responsible for scientific inquiries
Contact
Name of organization / entity
School of Traditional and Complementary Medicine, Mashhad University of Medical Sciences
Full name of responsible person
Dr. Hoda Azizi
Position
Assistant Professor
Latest degree
Ph.D.
Other areas of specialty/work
acupuncture and Chinese Medicine
Street address
Azadi Square
City
Mashhad
Province
Razavi Khorasan
Postal code
9177948564
Phone
+98 51 3882 9279
Fax
Email
azizih@mums.ac.ir
Web page address
Person responsible for updating data
Contact
Name of organization / entity
School of Traditional and Complementary Medicine
Full name of responsible person
Dr. Monirsadat Sahebkar-khorasani
Position
PhD candidate
Latest degree
Medical doctor
Other areas of specialty/work
Traditional Medicine
Street address
Park Square
City
Mashhad
Province
Razavi Khorasan
Postal code
9177948564
Phone
+98 51 3882 9279
Fax
Email
sahebkarm931@mums.ac.ir
Web page address
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available